[18F]-PSMA-1007-PET for evaluation of kidney function
Nuklearmedizin - NuclearMedicine · 01.08.2023 · 62 (04) · 244-251
DOI: 10.1055/a-2127-7880 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nuklearmedizin - NuclearMedicine, erschienen am 01.08.2023. Verfasst von Philipp Rassek und 3 weiteren Autor:innen. Beteiligte Einrichtung: Clinic for Nuclear Medicine, Universitiy Hospital Münster, Münster, Germany. Hauptthemen laut MEDLINE: Positron Emission Tomography Computed Tomography, Kidney. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 22 Literaturangaben. Gefördert von: Deutsche Forschungsgemeinschaft.
Abstract (Originalsprache)
Purpose
Prostate-specific membrane antigen (PSMA) is present in the proximal tubule cells of the kidneys. This results in high renal tracer uptake in PSMA-PET, which may contain useful information on renal function. As part of the evaluation for [177Lu]-PSMA therapies, patients undergo PSMA-PET and additional [99mTc]-mercapto-acetyltriglycine (MAG3) scintigraphy to assess renal function. Aim of this study was to evaluate estimation of renal function with [18F]-PSMA-1007-PET/CT (PSMA-PET) by comparison to timely MAG3-scintigraphies. Materials and Methods We retrospectively investigated 73 prostate cancer patients with 93 timely available PSMA-PET/CT, MAG3-scintigraphies and serum creatinine. For determination of split renal function in PSMA-PET/CT, we evaluated the relative unilateral total renal PSMA uptake, i.e. SUVmean multiplied by the renal volume (SRFPSMA-TOTAL) and relative unilateral maximal standardized uptake value (SRFSUV). These were compared to MAG3 split renal function (SRFMAG3) using Pearson correlation and receiver operating characteristics analysis. For determination of global renal function, correlation of bilateral total renal PSMA uptake with MAG3 tubular excretion rate and serum creatinine was assessed.
Results
SRFMAG3 was strongly correlated with SRFPSMA-TOTAL (r= 0.872, p
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Clinic for Nuclear Medicine, Universitiy Hospital Münster, Münster, Germany.
Förderung
- Deutsche Forschungsgemeinschaft
Zitieren
APA
Rassek, P., Schäfers, M., Rahbar, K., & Backhaus, P. (2023). [18F]-PSMA-1007-PET for evaluation of kidney function. Nuklearmedizin - NuclearMedicine, 62(04), 244-251. https://doi.org/10.1055/a-2127-7880
Vancouver
Rassek P, Schäfers M, Rahbar K, Backhaus P. [18F]-PSMA-1007-PET for evaluation of kidney function. Nuklearmedizin - NuclearMedicine. 2023;62(04):244-251. doi:10.1055/a-2127-7880
BibTeX
@article{Rassek2023,
author = {Rassek, Philipp and Schäfers, Michael and Rahbar, Kambiz and Backhaus, Philipp},
title = {[18F]-PSMA-1007-PET for evaluation of kidney function},
journal = {Nuklearmedizin - NuclearMedicine},
year = {2023},
volume = {62},
number = {04},
pages = {244--251},
doi = {10.1055/a-2127-7880}
}
EUVIMED